Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 06  •  04:00PM ET
36.35
Dollar change
+1.30
Percentage change
3.71
%
CategoryUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.S. Return% 1Y15.87% Total Holdings58 Perf Week1.00%
SponsorSimplify ETF ETF Type Tagsequity Return% 3Y11.05% AUM294.84M Perf Month-4.39%
Fund Family Bond Type Tagshealthcare Return% 5Y- NAV/sh Perf Quarter10.52%
Index- Average Maturity Tags- Return% 10Y 52W High38.68 -6.02% Perf Half Y27.81%
Index Weighting Commodity Type Tags- Return% SI 52W Low26.10 39.28% Perf YTD-0.68%
Active/Passive Quant Type Tags- Flows% 1M-10.40% Volatility2.17% 1.68% Perf Year18.21%
Dividend TTM0.25 (0.69%) ESG Type Tags- Flows% 3M19.97% ATR (14)0.70 Perf 3Y38.63%
Dividend Ex-DateDec 23, 2025 Dividend Type Sector/Theme Flows% YTD-11.63% RSI (14)46.56 Perf 5Y-
Dividend Gr. 3/5Y30.69% - Structure Type Region Flows% 1Y Beta0.74 Perf 10Y-
Expense0.51% Growth/Value SMA20-1.87% Flows% 3Y Rel Volume1.57 Prev Close35.05
Inverse/Leveraged Market Cap SMA50-1.84% Flows% 5Y Avg Volume225.39K Price36.35
IPOOct 08, 2021 Option/ShortYes / Yes SMA20012.46% Trades Volume353,847 Change3.71%
Jan-29-26 08:20AM
Jan-26-26 08:55AM
Nov-26-25 10:00AM
May-02-25 03:25AM
Apr-30-25 04:35AM
05:45AM Loading…
Apr-23-25 05:45AM
Apr-18-25 01:40PM
Apr-04-25 08:30AM
Apr-02-25 07:00AM
Apr-01-25 05:40AM
Mar-28-25 06:05AM
Mar-20-25 04:32PM
Feb-28-24 01:30PM
Dec-15-23 07:00PM
Oct-31-23 03:00AM
09:05AM Loading…
Oct-12-22 09:05AM
May-17-22 08:56AM
Dec-28-21 08:57AM
Simplify Health Care ETF seeks long-term capital appreciation. Under normal circumstances, the fund will invest at least 80% of its assets (plus any borrowings for investment purposes) in securities of U.S. health care companies. The fund adviser defines health care companies as companies included in the Global Industry Classification Standard health care sector. The fund will typically invest in 50 - 100 health care companies. The adviser generally seeks investments in companies that are developing new and effective medicines, as well as companies whose business models reduce costs or improve quality in health care systems.